NEW YORK, NY and SOUTH SAN FRANCISCO, CA--(MARKET WIRE)--Sep 20, 2007 -- The Juvenile Diabetes Research Foundation, the world’s largest charitable funder of type 1 diabetes research, today announced a partnership with CoMentis, Inc. to support the biotechnology company’s human clinical trial of ATG3, a topical eye drop therapy for diabetic macular edema.
